Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Medico Remedies IPO and Sintercom India IPO.
Medico Remedies IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Sintercom India IPO is a SME Book Built Issue proposed to list at NSE SME.
| Medico Remedies IPO | Sintercom India IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Book Built Issue |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Aryaman Financial Services Limited | Pantomath Capital Advisors Pvt Ltd |
| Registrar | Cameo Corporate Services Limited | Link Intime India Private Ltd |
| Market Maker | ||
| DRHP | DRHP  |
|
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Medico Remedies IPO is up to ₹10.99 Cr whereas the issue size of the Sintercom India IPO is up to ₹42.55 Cr. The final issue price of Medico Remedies IPO is ₹100.00 per share and of Sintercom India IPO is ₹65.00 per share.
| Medico Remedies IPO | Sintercom India IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹63.00 per share | |
| Issue Price (Upper) | ₹65.00 per share | |
| Issue Price (Final) | ₹100.00 per share | ₹65.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 2000 shares |
| Fresh Issue Size | 30,16,000 shares | |
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | 35,30,000 shares | |
| OFS Issue Size (Amount) | ||
| Issue Size Total | 10,99,200 shares | 65,46,000 shares |
| Issue Size Total (Amount) | up to ₹10.99 Cr | up to ₹42.55 Cr |
Medico Remedies IPO opens on Jan 29, 2018, while Sintercom India IPO opens on Feb 05, 2018. The closing date of Medico Remedies IPO and Sintercom India IPO is Jan 31, 2018, and Feb 07, 2018, respectively.
| Medico Remedies IPO | Sintercom India IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 29, 2018 | Feb 05, 2018 |
| Issue Close | Jan 31, 2018 | Feb 07, 2018 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Medico Remedies IPO P/E ratio is , as compared to Sintercom India IPO P/E ratio of .
| Medico Remedies IPO | Sintercom India IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Medico Remedies IPO retail investors (RII) are offered 5,20,800 shares while in Sintercom India IPO retail investors are offered 5,20,800 shares. Qualified institutional buyers (QIB) are offered 0 shares in Medico Remedies IPO and 30,81,000 shares in Sintercom India IPO.
| Medico Remedies IPO | Sintercom India IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 57,600 shares | 3,34,000 shares |
| QIB | 0 shares | 30,81,000 shares |
| NII | 5,20,800 shares | 9,24,300 shares |
| RII | 5,20,800 shares | 21,56,700 shares |
| Employee | 50,000 shares | |
| Others | ||
| Total | 10,99,200 shares | 62,12,000 shares |
Medico Remedies IPO subscribed 1.84x in total, whereas Sintercom India IPO subscribed 38.92x.
| Medico Remedies IPO | Sintercom India IPO | |
|---|---|---|
| QIB (times) | 5.80x | |
| NII (times) | 1.16x | 203.72x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.52x | 16.41x |
| Employee (times) | 3.92x | |
| Other (times) | ||
| Total (times) | 1.84x | 38.92x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
